Abstract
Background
Endoscopic ultrasonography (EUS) is an integrated part of the pretherapeutic evaluation program for patients with upper gastrointestinal (GI) tract cancer. Whether the clinical impact of EUS differs between surgeons from different countries is unknown. The same applies to the potential clinical influence of EUS misinterpretations. The aim of this study was to evaluate the interobserver agreement on predefined treatment strategies between surgeons from four different countries, with and without EUS, and to evaluate the clinical consequences of EUS misinterpretations.
Methods
One hundred patients with upper GI tract cancer were randomly selected from all upper GI tract cancer patients treated at Odense University Hospital between 1997 and 2000. Based on patient records and EUS database results, a case story was created with and without the EUS result for each patient. Four surgeons were asked to select the relevant treatment strategy in each case, at first without knowledge of the EUS and thereafter with the EUS result available. Interobserver agreement and impact of EUS misinterpretations were evaluated using the actual final treatment of each patient as reference.
Results
Three of four or all four surgeons agreed on the same treatment strategy for nearly 60% of the patients with and without the EUS results. Treatment decisions were changed in 34% based on the EUS results, and the majority of these changes were toward nonsurgical and palliative treatments (85%). Interobserver agreement was relatively low, but overall EUS increased kappa values from 0.16 (“poor”) to 0.33 (“fair”), thus indicating increased overall agreement after the EUS results were available. EUS conclusion regarding stage or resectability was wrong in 17% of the cases, but only one serious event would have been the clinical result of EUS misinterpretations.
Conclusion
Despite being used in different ways by different surgeons, EUS did change patient management in one third of the cases. The impact of EUS misinterpretations seemed very low, and this study confirmed one of the strongest clinical possibilities of EUS, i.e., the ability to detect nonresectable cases. EUS is an important imaging modality for oncosurgeons from different countries.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Beger HG, Rau B, Gansauge F, Poch B, Link KH (2003) Treatment of pancreatic cancer: challenge of the facts. World J Surg 27: 1075–1084
Harewood GC, Kumar KS (2004) Assessment of clinical impact of endoscopic ultrasound on esophageal cancer. J Gastroenterol Hepatol 19: 433–439
Hunerbein M, Ulmer C, Handke T, Schlag PM (2003) Endosonography of upper gastrointestinal tract cancer on demand using miniprobes or endoscopic ultrasound. Surg Endosc 17: 615–619
Hunerbein M, Handke T, Ulmer C, Schlag PM (2004) Impact of miniprobe ultrasonography on planning of minimally invasive surgery for gastric and colonic tumors. Surg Endosc 18: 601–605
Jafri IH, Saltzman JR, Colby JM, Krims PE (1996) Evaluation of the clinical impact of endoscopic ultrasonography in gastrointestinal disease. Gastrointest Endosc 44: 367–370
Kelly S, Harris KM, Berry E, Hutton J, Roderick P, Cullingworth J, Gathercole L, Smith MA (2001) A systematic review of the staging performance of endoscopic ultrasound in gastro-oesophageal carcinoma. Gut 49: 534–539
Mortensen MB, Pless T, Durup J, Ainsworth AP, Plagborg GJ, Hovendal C (2001) Clinical impact of endoscopic ultrasound-guided fine needle aspiration biopsy in patients with upper gastrointestinal tract malignancies. A prospective study. Endoscopy 33: 478–483
Mortensen MB, Scheel-Hincke JD, Madsen MR, Qvist N, Hovendal C (1996) Combined endoscopic ultrasonography and laparoscopic ultrasonography in the pretherapeutic assessment of resectability in patients with upper gastrointestinal malignancies. Scand J Gastroenterol 31: 1115–1119
Nickl NJ, Bhutani MS, Catalano M, Hoffman B, Hawes R, Chak A, Roubein LD, Kimmey M, Johnson M, Affronti J, Canto M, Sivak M, Boyce HW, Lightdale CJ, Stevens P, Schmitt C (1996) Clinical implications of endoscopic ultrasound: the American Endosonography Club Study. Gastrointest Endosc 44: 371–377
Preston SR, Clark GW, Martin IG, Ling HM, Harris KM (2003) Effect of endoscopic ultrasonography on the management of 100 consecutive patients with oesophageal and junctional carcinoma. Br J Surg 90: 1220–1224
Shumaker DA, de Garmo P, Faigel DO (2002) Potential impact of preoperative EUS on esophageal cancer management and cost. Gastrointest Endosc 56: 391–396
Siewert JR, Stein HJ, Sendler A, Fink U (1999) Surgical resection for cancer of the cardia. Semin Surg Oncol 17: 125–131
Vazquez-Sequeiros E, Wiersema MJ, Clain JE, Norton ID, Levy MJ, Romero Y, Salomao D, Dierkhising R, Zinsmeister AR (2003) Impact of lymph node staging on therapy of esophageal carcinoma. Gastroenterology 125: 1626–1635
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mortensen, M.B., Edwin, B., Hünerbein, M. et al. Impact of endoscopic ultrasonography (EUS) on surgical decision-making in upper gastrointestinal tract cancer: An international multicenter study. Surg Endosc 21, 431–438 (2007). https://doi.org/10.1007/s00464-006-9029-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-006-9029-3